合成路线1
该中间体在本合成路线中的序号:
(I) A new method for the synthesis of encainide has been reported:
The acylation of methyl anthranilate (I) with 4-anisoyl chloride (II) by means of NaOH in methylene chloride gives methyl N-(p-anisoyl)anthranilate (III), which is condensed with 2-picoline (IV) by means of n-butyllithium in THF yielding 2-(2-pyridylacetyl)-p-anisanilide (V). Finally, this compound is reduced with H2 over Pt/C then with Pd/C, treated with formaldehyde and reduced again with H2 over Pt/C.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11161 |
methyl 2-aminobenzoate; Methyl anthranilate
|
134-20-3 |
C8H9NO2 |
详情 | 详情
|
(II) |
22671 |
4-Methoxybenzoyl chloride; p-Methoxybenzoyl chloride; 4-Anisoyl chloride
|
100-07-2 |
C8H7ClO2 |
详情 | 详情
|
(III) |
29100 |
methyl 2-[(4-methoxybenzoyl)amino]benzoate
|
|
C16H15NO4 |
详情 |
详情
|
(IV) |
17590 |
2-methylpyridine; 2-picoline
|
109-06-8 |
C6H7N |
详情 | 详情
|
(V) |
29101 |
4-methoxy-N-[2-[2-(2-pyridinyl)acetyl]phenyl]benzamide
|
|
C21H18N2O3 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(II) Synthesis of the intermediate 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one (IV) is accomplished by condensation of 3-amino-2-chloropyridine (I) and the anthranilic ester (II) using potassium tert-butoxide as a catalyst. The resulting anthranilic amide (III) is cyclized under the influence of catalytic amounts of sulfuric acid. Treatment of (IV) with chloroacetylchloride in toluene furnishes the corresponding chloroacetamide (V).
The diamine part of AF-DX 116 is prepared starting from 2-(hydroxymethyl)piperidine (VI). Reaction with thionylchloride in dichloromethane affords the pipecolylchloride hydrochloride (VII), which is converted with diethylamine to the required 2-[(diethylamino)methyl]piperidine (IX) via nucleophilic ring opening of the intermediate aziridine (VIII). Minor amounts of 3-(diethylamino)hexahydroazepine (X), formed by a side reaction, are separated by thorough fractional distillation of the diamine (IX) and/or recrystallization of its hydrochloride (XI).
Coupling of (V) and (XI) in the presence of sodium carbonate yields AF-DX 116 as its free base.
【1】
Schmidt, G.; Hammer, R.; Giachetti, A.; Engel, W.; Trummlitz, G.; Eberlein, W.; Mihm, G. (Dr. Karl Thomae GmbH); Condensed diazepinones, process for their preparation and medicines containing them. AU 8539815; EP 0156191; ES 8607282; ES 8702908; JP 1985215683; US 4550107 . |
【2】
Mattson, R.J.; Yevich, J.P.; Eison, M.S. (Bristol-Myers Squibb Co.); Cerebral function enhancing diazinylpiperidine derivs. AU 8659787; BE 0905061; CH 671579; DE 3622842; FR 2584408; GB 2177692; US 4826843 .
|
【3】
Eberlein, W.G.; Trummlitz, G.; Mihm, G.; Engel, W.W.; Hammer, R.; Tricyclic compounds as selective muscarinic receptor antagonists. 3. Structure-selectivity relationships in a series of cardioselective (M2) antimuscarinics. J Med Chem 1989, 32, 8, 1718-24. |
【4】
Engel, W.; Doods, H.; Wetzel, B.; AF-DX 116. Drugs Fut 1990, 15, 1, 9.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11160 |
2-Chloro-3-pyridinamine; 2-Chloro-3-pyridinylamine; 3-Amino-2-chloropyridine; 2-Chloro-3-aminopyridine
|
6298-19-7 |
C5H5ClN2 |
详情 | 详情
|
(II) |
11161 |
methyl 2-aminobenzoate; Methyl anthranilate
|
134-20-3 |
C8H9NO2 |
详情 | 详情
|
(III) |
11162 |
2-Amino-N-(2-chloro-3-pyridinyl)benzamide
|
|
C12H10ClN3O |
详情 |
详情
|
(IV) |
11163 |
5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one
|
|
C12H9N3O |
详情 |
详情
|
(V) |
11164 |
11-(2-Chloroacetyl)-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one
|
|
C14H10ClN3O2 |
详情 |
详情
|
(VI) |
11165 |
2-Piperidinylmethanol; 2-Piperidinemethanol
|
3433-37-2 |
C6H13NO |
详情 | 详情
|
(VII) |
11166 |
2-(Chloromethyl)piperidine
|
|
C6H12ClN |
详情 |
详情
|
(VIII) |
11167 |
1-Azabicyclo[4.1.0]heptane
|
|
C6H11N |
详情 |
详情
|
(IX) |
11168 |
N-Ethyl-N-(2-piperidinylmethyl)-1-ethanamine; N-(2-Piperidylmethyl)-diethylamine; N,N-Diethyl-N-(2-piperidinylmethyl)amine
|
64168-09-8 |
C10H22N2 |
详情 | 详情
|
(X) |
11169 |
N,N-Diethyl-3-azepanamine; N-(3-Azepanyl)-N,N-diethylamine
|
|
C10H22N2 |
详情 |
详情
|
(XI) |
11170 |
N-Ethyl-N-(2-piperidinylmethyl)-1-ethanamine hydrochloride
|
|
C10H23ClN2 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(I) The cyclization of methyl 2-aminobenzoate (I) with 2,5-dimethoxytetrahydrofuran (II) in refluxing acetic acid gives methyl 2-(pyrrol-1-yl)benzoate (III), which by reduction with LiAlH4 in ether is converted into 2-(pyrrol-1-yl)benzyl alcohol (IV). The cyclization of (IV) with ethyl 2-oxopropionate (V) by means of butyllithium and tetramethylethylenediamine (TMEDA) in THF affords 4-methyl-4H,6H-pyrrolo[1,2-a][4,1]benzoxazepine-4-carboxylic acid ethyl ester (VI), which is hydrolyzed with NaOH in refluxing ethanol to the corresponding free acid (VII). The condensation of (VII) with 1-(piperidin-4-yl)-2,3-dihydro-1H-benzimidazol-2-one (VIII) by means of carbonyldiimidazol (CDI) in THF gives 1-[1-(4-methyl-4H,6H-pyrrolo[1,2-a][4,1]benzoxazepin-4-ylcarbonyl) piperidin-4-yl]-2,3-dihydro-1H-benzimidazol-2-one (IX), which is finally reduced with LiAlH4 in THF, and treated with maleic acid in acetone.
【1】
Robinson, C.; Robinson, K.; Castaner, J.; Zaldaride Maleate. Drugs Fut 1996, 21, 7, 719.
|
【2】
Wasley, J.W.F.; Norman, J. (Novartis AG); Pyrrolo[1,2-a][4,1]benzoxazepins, process for their preparation, pharmaceutical compsns. containing them as well as therapeutic use. EP 0233483; JP 1987169791; JP 1995089966; US 4758559 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11161 |
methyl 2-aminobenzoate; Methyl anthranilate
|
134-20-3 |
C8H9NO2 |
详情 | 详情
|
(II) |
12132 |
2,5-Dimethoxytetrahydrofuran; 5-Methoxytetrahydro-2-furanyl methyl ether
|
696-59-3 |
C6H12O3 |
详情 | 详情
|
(III) |
12133 |
methyl 2-(1H-pyrrol-1-yl)benzoate
|
|
C12H11NO2 |
详情 |
详情
|
(IV) |
12134 |
[2-(1H-Pyrrol-1-yl)phenyl]methanol
|
|
C11H11NO |
详情 |
详情
|
(V) |
12135 |
ethyl 2-oxopropanoate; Ethyl pyruvate
|
617-35-6 |
C5H8O3 |
详情 | 详情
|
(VI) |
12136 |
ethyl 4-methyl-4H,6H-pyrrolo[1,2-a][4,1]benzoxazepine-4-carboxylate
|
|
C16H17NO3 |
详情 |
详情
|
(VII) |
12137 |
4-Methyl-4H,6H-pyrrolo[1,2-a][4,1]benzoxazepine-4-carboxylic acid
|
|
C14H13NO3 |
详情 |
详情
|
(VIII) |
12138 |
1-(4-Piperidinyl)-1,3-dihydro-2H-benzimidazol-2-one; 4-(2-Keto-1-benzimidazolinyl)piperidine
|
20662-53-7 |
C12H15N3O |
详情 | 详情
|
(IX) |
12139 |
1-[1-[(4-Methyl-4H,6H-pyrrolo[1,2-a][4,1]benzoxazepin-4-yl)carbonyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one
|
|
C26H26N4O3 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(II) Synthesis of the intermediate diazepinone (IV) is accomplished by a one-pot synthesis. Condensation of 2-chloro-3-aminopyridine (I) with the anthranilic ester (II) is effected in the presence of potassium tert-butoxide as a catalyst. The resulting anthranilic amide (III) is cyclized under the influence of catalytic amounts of sulfuric acid. Treatment of (IV) with chloroacetylchloride in toluene yields the corresponding choroacetamide (V).
The side chain of AQ-RA 741 is prepared starting from 4-picoline, which is alkylated by reaction with 3-(diethylamino)propylchloride in the presence of n-butyllithium. Hydrogenation of (VIII) using platinum dioxide as a catalyst furnishes the diamine (IX), which is coupled with (V) in the presence of catalytic amounts of sodium iodide in acetone leading to AQ-RA 741 as its free base.
【1】
Eberlein, W.; Engel, W.; Trummlitz, G.; Mihm, G.; Mayer, N.; Doods, H. (Dr. Karl Thomae GmbH); Condensed diazepinones, process for their preparation and medicines containing them. AU 8824122; DE 3735895; EP 0312895; JP 1989230580; US 5175158 .
|
【2】
Eberlein, W.; Doods, H.; Wetzel, B.; AQ-RA-741. Drugs Fut 1990, 15, 8, 786.
|
【3】
LaMontagne, M.P.; et al.; Tricyclic compounds as selective muscarinic receptor antagonists. 3.
Structure-selectivity relationships in a series of cardioselective (M2) antimuscarinics. J Med Chem 1989, 32, 8, 1728-32.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(I) |
11160 |
2-Chloro-3-pyridinamine; 2-Chloro-3-pyridinylamine; 3-Amino-2-chloropyridine; 2-Chloro-3-aminopyridine
|
6298-19-7 |
C5H5ClN2 |
详情 | 详情
|
(II) |
11161 |
methyl 2-aminobenzoate; Methyl anthranilate
|
134-20-3 |
C8H9NO2 |
详情 | 详情
|
(III) |
11162 |
2-Amino-N-(2-chloro-3-pyridinyl)benzamide
|
|
C12H10ClN3O |
详情 |
详情
|
(IV) |
11163 |
5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one
|
|
C12H9N3O |
详情 |
详情
|
(V) |
11164 |
11-(2-Chloroacetyl)-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one
|
|
C14H10ClN3O2 |
详情 |
详情
|
(VI) |
31150 |
4-methylpyridine
|
108-89-4 |
C6H7N |
详情 | 详情
|
(VII) |
31151 |
N-(3-chloropropyl)-N,N-diethylamine; 3-chloro-N,N-diethyl-1-propanamine
|
|
C7H16ClN |
详情 |
详情
|
(VIII) |
31152 |
N,N-diethyl-N-[4-(4-pyridinyl)butyl]amine; N,N-diethyl-4-(4-pyridinyl)-1-butanamine
|
|
C13H22N2 |
详情 |
详情
|
(IX) |
31153 |
N,N-diethyl-N-[4-(4-piperidinyl)butyl]amine; N,N-diethyl-4-(4-piperidinyl)-1-butanamine
|
|
C13H28N2 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(I) The acylation of methylanthranilate (I) with isobutyryl chloride (II) gives 2-isobutyramidobenzoic acid methyl ester (III), which is reduced with LiAlH4 to 2-(isobutylamino)benzyl alcohol (IV). The methylation of (IV) with dimethyl sulfate yields 2-(N-isobutyl-N-methylamino)benzyl alcohol (V), which is treated with SOCl2 to afford the corresponding benzyl chloride (VI). The condensation of (VI) with benzimidazole-2-thiol (VII) by means of NaOH yields 2-[2-(N-isobutyl-N-methylamino)benzylsulfanyl)benzimidazole (VIII), which is finally oxidized with m-chloroperbenzoic acid (MCPBA) as usual.
【1】
Mealy, N.; Castaner, J.; Leminoprazole. Drugs Fut 1996, 21, 2, 155.
|
【2】
Mazaki, M.; Yamakawa, T.; Nomura, Y. (Nippon Chemiphar Co., Ltd.); Method for the preparation of benzimidazole cpds. JP 1990078665 .
|
【3】
Okabe, S.; Sato, M.; Yamakawa, T.; Nomura, T.; Hayashi, M. (Nippon Chemiphar Co., Ltd.); Cytoprotective agents for stomach and intestine. JP 1988230633 .
|
【4】
Susumu, O.; Masaru, S.; Tomio, Y.; Yutaka, N.; Masatoshi, H. (Nippon Chemiphar Co., Ltd.); Benzimidazole derivs. and antiulcer agents contain. AU 8546409; BE 0903128; CH 665417; DE 3531487; ES 8703142; FR 2569691; GB 2163747; JP 1986060660; JP 1986221175; JP 1986221176; JP 1991223260; JP 1991223261; JP 1991223262; JP 1991227927 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11161 |
methyl 2-aminobenzoate; Methyl anthranilate
|
134-20-3 |
C8H9NO2 |
详情 | 详情
|
(II) |
14932 |
isobutyryl chloride; 2-methylpropanoyl chloride
|
79-30-1 |
C4H7ClO |
详情 | 详情
|
(III) |
14933 |
methyl 2-(isobutyrylamino)benzoate
|
|
C12H15NO3 |
详情 |
详情
|
(IV) |
14934 |
[2-(isobutylamino)phenyl]methanol
|
|
C11H17NO |
详情 |
详情
|
(V) |
14935 |
[2-[isobutyl(methyl)amino]phenyl]methanol
|
|
C12H19NO |
详情 |
详情
|
(VI) |
14936 |
2-(chloromethyl)-N-isobutyl-N-methylaniline; N-[2-(chloromethyl)phenyl]-N-isobutyl-N-methylamine
|
|
C12H18ClN |
详情 |
详情
|
(VII) |
12821 |
2-Mercaptobenzinidiazole; 1H-Benzimidazol-2-ylhydrosulfide; 1H-Benzimidazole-2-thiol; 2-Benzimidazolethiol; o-Phenylenethiourea; 2-Benzimidazolinethione; 1,3-Dihydro-2H-benzimidazole-2-thione
|
583-39-1 |
C7H6N2S |
详情 | 详情
|
(VIII) |
14938 |
2-[(1H-benzimidazol-2-ylsulfanyl)methyl]-N-isobutyl-N-methylaniline; N-[2-[(1H-benzimidazol-2-ylsulfanyl)methyl]phenyl]-N-isobutyl-N-methylamine
|
|
C19H23N3S |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(I) The reaction of methyl anthranilate (I) with tetrahydrofuran-2,4-dione (II) by means of HCl in ethanol gives 2-(5-oxo-2,5-dihydrofuran-3-ylamino)benzoic acid methyl ester (III), which is cyclized by means of polyphosphoric acid (PPA) at 130-140 C yielding the tricyclic hydroxyketone (IV). The condensation of (IV) with 4-(2-aminoethyl)-1-benzylpiperidine (V) in N-methyl-2-pyrrolidone by a Dean-Stark elimination of water affords 2-[2-(1-benzyl-piperidin-4-yl)ethyl]-9-hydroxy-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one (VI), which is finally methylated with diazomethane in methanol.
【1】
Castañer, J.; Mucke, H.A.M.; T-82. Drugs Fut 1998, 23, 10, 1075-1077.
|
【2】
Hasegawa, H.; Isomae, K.; Kotsugai, T.; Shioiri, N.; Sekine, K.; Taido, N.; Sato, S.; Kuraishi, T. (SSP Co., Ltd.); Quinoline derivs.. EP 0481429; JP 1993009188; JP 1993279355; US 5190951; US 5240934; US 5300517 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11161 |
methyl 2-aminobenzoate; Methyl anthranilate
|
134-20-3 |
C8H9NO2 |
详情 | 详情
|
(II) |
17603 |
Tetronic acid; 2,4(3H,5H)-Furandione
|
4971-56-6 |
C4H4O3 |
详情 | 详情
|
(III) |
17604 |
methyl 2-[(5-oxo-2,5-dihydro-3-furanyl)amino]benzoate
|
|
C12H11NO4 |
详情 |
详情
|
(IV) |
17605 |
9-hydroxyfuro[3,4-b]quinolin-1(3H)-one
|
|
C11H7NO3 |
详情 |
详情
|
(V) |
17606 |
2-(1-benzyl-4-piperidinyl)-1-ethanamine; 2-(1-benzyl-4-piperidinyl)ethylamine
|
|
C14H22N2 |
详情 |
详情
|
(VI) |
17607 |
2-[2-(1-benzyl-4-piperidinyl)ethyl]-9-hydroxy-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one
|
|
C25H27N3O2 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(III) 4-[6-(Cyclohexyloxy)-2-naphthyloxy]phenylacetic acid (I) was converted to acid chloride (II) by treatment with oxalyl chloride and catalytic DMF. Subsequent coupling of (II) with methyl anthranilate (III) produced the corresponding amide (IV). The methyl ester group of (IV) was finally hydrolyzed with LiOH in THF-MeOH.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
36344 |
2-(4-[[6-(cyclohexyloxy)-2-naphthyl]oxy]phenyl)acetic acid
|
|
C24H24O4 |
详情 |
详情
|
(II) |
36345 |
2-(4-[[6-(cyclohexyloxy)-2-naphthyl]oxy]phenyl)acetyl chloride
|
|
C24H23ClO3 |
详情 |
详情
|
(III) |
11161 |
methyl 2-aminobenzoate; Methyl anthranilate
|
134-20-3 |
C8H9NO2 |
详情 | 详情
|
(IV) |
36346 |
methyl 2-[[2-(4-[[6-(cyclohexyloxy)-2-naphthyl]oxy]phenyl)acetyl]amino]benzoate
|
|
C32H31NO5 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(I) Benzothiadiazine dioxide (II) was prepared by cyclization of methyl anthranylate (I) with sulfamoyl chloride, followed by aqueous NaOH. After silylation of (II) by means of hexamethyldisilazane, alkylation with benzyloxymethyl acetate (III) in the presence of boron trifluoride etherate produced the 3-(benzyloxymethyl)benzothiazine (IV). Further alkylation of (IV) with benzyl bromide in aqueous NaHCO3 furnished the title compound.
【1】
Esteban, A.I.; Martinez, A.; De Clercq, E.; Benzothiadiazine dioxide acyclonucleosides as lead compounds for the development of new agents against human cytomegalovirus and varicella-zoster virus infection. Bioorg Med Chem Lett 1997, 7, 8, 1031.
|
【2】
Martinez, A.; et al.; Novel potential agents for human cytomegalovirus infection: Synthesis and antiviral activity evaluation of benzothiadiazine dioxide acyclonucleosides. J Med Chem 1999, 42, 7, 1145.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
12912 |
1-(Bromomethyl)benzene; Alpha-bromotoluene
|
100-39-0 |
C7H7Br |
详情 | 详情
|
|
40598 |
amidosulfonoyl chloride
|
7778-42-9 |
H2ClNO2S |
详情 | 详情
|
(I) |
11161 |
methyl 2-aminobenzoate; Methyl anthranilate
|
134-20-3 |
C8H9NO2 |
详情 | 详情
|
(II) |
34452 |
2lambda(6),1,3-benzothiadiazine-2,2,4(1H,3H)-trione
|
|
C7H6N2O3S |
详情 |
详情
|
(III) |
34453 |
(benzyloxy)methyl acetate
|
|
C10H12O3 |
详情 |
详情
|
(IV) |
34454 |
3-[(benzyloxy)methyl]-2lambda(6),1,3-benzothiadiazine-2,2,4(1H,3H)-trione
|
|
C15H14N2O4S |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(I) Benzothiadiazine S,S-dioxide (II) was obtained by a two-step condensation of methyl anthranylate (I) and sulfamoyl chloride following a reported procedure (1). The alkylation of (II) with 3,4-dichlorobenzyl chloride (III) in the presence of NaHCO3 furnished the title compound.
【1】
J Am Chem Soc 1962, 84, 1994-2000.
|
【2】
Castro, A.; Gil, C.; Martinez, A.; et al.; Benzyl derivatives of 2,1,3-benzo- and benzothieno[3,2-a]thiadiazine 2,2-dioxides: First phosphodiesterase 7 inhibitors. J Med Chem 2000, 43, 4, 683.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11161 |
methyl 2-aminobenzoate; Methyl anthranilate
|
134-20-3 |
C8H9NO2 |
详情 | 详情
|
(II) |
34452 |
2lambda(6),1,3-benzothiadiazine-2,2,4(1H,3H)-trione
|
|
C7H6N2O3S |
详情 |
详情
|
(III) |
19333 |
1,2-dichloro-4-(chloromethyl)benzene
|
102-47-6 |
C7H5Cl3 |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(I) Methyl anthranilate (I) was condensed with chloral hydrate and hydroxylamine to produce the hydroxymino acetamide (II), which was cyclized to the required isatin-7-carboxylic acid (III) in hot concentrated sulfuric acid. The Pfitzinger condensation of isatin (III) with 7-methyl-1-indanone (IV) gave rise to indenoquinoline (V). Ketone (VI) was then obtained by oxidation of (V) with potassium permanganate in the presence of sodium carbonate. Subsequent thermal decarboxylation of diacid (VI) afforded monocarboxylic acid (VII) (1). After activation of acid (VII) as the corresponding imidazolide (VIII) upon treatment with N,N'-carbonyl diimidazole, coupling with tetraamine (IX) furnished the title bisamide.
【1】
Finlay, G.J.; Baguley, B.C.; Desneves, J.; Kaye, A.J.; Denny, W.A.; Deady, L.W.; Synthesis and antitumor activity of some indeno[1,2-b]quinoline-based bis carboxamides. Bioorg Med Chem 2000, 8, 5, 977.
|
【2】
Denny, W.A.; Deady, L.W.; Kaye, A.J. (La Trobe University); Topoisomerase inhibitors. WO 9845272 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11161 |
methyl 2-aminobenzoate; Methyl anthranilate
|
134-20-3 |
C8H9NO2 |
详情 | 详情
|
(II) |
42161 |
methyl 2-[[2-(hydroxyimino)acetyl]amino]benzoate
|
|
C10H10N2O4 |
详情 |
详情
|
(III) |
42162 |
2,3-dioxo-7-indolinecarboxylic acid
|
|
C9H5NO4 |
详情 |
详情
|
(IV) |
42163 |
7-methyl-1-indanone
|
|
C10H10O |
详情 |
详情
|
(V) |
42164 |
4-methyl-11H-indeno[1,2-b]quinoline-6,10-dicarboxylic acid
|
|
C19H13NO4 |
详情 |
详情
|
(VI) |
42165 |
4-methyl-11-oxo-11H-indeno[1,2-b]quinoline-6,10-dicarboxylic acid
|
|
C19H11NO5 |
详情 |
详情
|
(VII) |
42166 |
4-methyl-11-oxo-11H-indeno[1,2-b]quinoline-6-carboxylic acid
|
|
C18H11NO3 |
详情 |
详情
|
(VIII) |
42167 |
6-(1H-imidazol-1-ylcarbonyl)-4-methyl-11H-indeno[1,2-b]quinolin-11-one
|
|
C21H13N3O2 |
详情 |
详情
|
(IX) |
42168 |
N(1),N(3)-bis(2-aminoethyl)-N(1),N(3)-dimethyl-1,3-propanediamine; N-(2-aminoethyl)-N-[3-[(2-aminoethyl)(methyl)amino]propyl]-N-methylamine
|
|
C9H24N4 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(A) 1) Condensation of 2-trifluoromethylaniline (I) with ethyl ethoxymethylenemalonate (II) at 125 C to give ethyl-alpha-carbethoxy-beta-(2-trifluoromethylanilino)acrylate (III), m.p. 94 C; this product is cyclized by refluxing with diphenyl ether affording 3-carbethoxy-4-hydroxy-8-trifluoromethylquinoline (IV), m.p. 216 C, which in turn, is hydrolyzed with refluxing aqueous NaOH to the corresponding acid (V), m.p. 290-2 C; this acid is decarboxylated by refluxing in diphenyl ether to 4-hydroxy-8-trifluoromethylquinoline (VI), m.p. 180 C; this product by refluxing with POCl3 is converted into chloro-8-trifluoromethylquinoline (VII), m.p. 78 C; the condensation of quinoline (VII) with methyl anthranilate (A) by means of aqueous 2N HCl affords 4-(2-methoxycarbonylphenylamino)-8-trifluoromethylquinoline (VIII), m.p. 176 C (1,2). The transesterification of methyl ester (VIII) with glycerol affords the final product. (1)
2) Transesterification of methylester (VIII) with 2,2-dimethyl-4-hydroxymethyl-1,3-dioxolane (B) to give the acetoneketal of floctafenine (IX), mp 108 C which is finally hydrolized with HCl. (2)
3) Condensation of the chloroquinoline (VII) with the 2,2-dimethyl-4-hydroxymethyl-2,3-dioxolane ester of anthranilic acid by means aqueous HCl to give the already obtained acetoneketal (IX), which is finally hydrolized as before. (2)
【1】
(Roussel-Uclaf.); DE 1815467 .
|
【2】
Castaner, J.; Arrigoni, Martelli, E.; Floctafenine. Drugs Fut 1976, 1, 2, 59.
|
【3】
Allais, A.; et al.; NMR structure of tissue inhibitor of metalloproteinases-1 implicates localized induced fit in recognition of matrix metalloproteinases. Chim Ther 1973, 8, 2, 154.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
11161 |
methyl 2-aminobenzoate; Methyl anthranilate
|
134-20-3 |
C8H9NO2 |
详情 | 详情
|
(B) |
16476 |
2,2-dimethyl-4-hydroxymethyl-1,3-dioxolane; (2,2-dimethyl-1,3-dioxolan-4-yl)methanol; 2,3-o-Isopropylideneglycerol
|
100-79-8 |
C6H12O3 |
详情 | 详情
|
(I) |
25812 |
2-(trifluoromethyl)phenylamine; 2-(trifluoromethyl)aniline
|
88-17-5 |
C7H6F3N |
详情 | 详情
|
(II) |
14088 |
Diethyl ethoxymethylenemalonate; Diethyl 2-(ethoxymethylene)malonate
|
87-13-8 |
C10H16O5 |
详情 | 详情
|
(III) |
60720 |
diethyl 2-{[2-(trifluoromethyl)anilino]methylene}malonate
|
|
C15H16F3NO4 |
详情 |
详情
|
(IV) |
60721 |
ethyl 4-hydroxy-8-(trifluoromethyl)-3-quinolinecarboxylate
|
|
C13H10F3NO3 |
详情 |
详情
|
(V) |
60722 |
4-hydroxy-8-(trifluoromethyl)-3-quinolinecarboxylic acid
|
|
C11H6F3NO3 |
详情 |
详情
|
(VI) |
60723 |
8-(trifluoromethyl)-4-quinolinol
|
|
C10H6F3NO |
详情 |
详情
|
(VII) |
60724 |
4-chloro-8-(trifluoromethyl)quinoline
|
|
C10H5ClF3N |
详情 |
详情
|
(VIII) |
60727 |
methyl 2-{[8-(trifluoromethyl)-4-quinolinyl]amino}benzoate
|
|
C18H13F3N2O2 |
详情 |
详情
|
(IX) |
60726 |
(2,2-dimethyl-1,3-dioxolan-4-yl)methyl 2-{[8-(trifluoromethyl)-4-quinolinyl]amino}benzoate
|
|
C23H21F3N2O4 |
详情 |
详情
|
(C) |
60725 |
(2,2-dimethyl-1,3-dioxolan-4-yl)methyl 2-aminobenzoate
|
|
C13H17NO4 |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(I)
【1】
Tsunoda T, Tanaka A, et al.2004.Anew synthetic route to YM087, an argirune asopressin antagonist.Heterocycles, 63: 1113---1122 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
14763 |
1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one
|
|
C17H17NO3S |
详情 |
详情
|
(I) |
11161 |
methyl 2-aminobenzoate; Methyl anthranilate
|
134-20-3 |
C8H9NO2 |
详情 | 详情
|
(II) |
66212 |
methyl 2-(4-methylphenylsulfonamido)benzoate |
|
C15H15NO4S |
详情 | 详情
|
(III) |
66213 |
methyl 2-(N-(3-cyanopropyl)-4-methylphenylsulfonamido)benzoate |
|
C19H20N2O4S |
详情 | 详情
|
(IV) |
66214 |
4-ethynyl-1-tosyl-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one |
|
C19H17N2O3S |
详情 | 详情
|
(VI) |
41815 |
4-bromo-1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one
|
|
C17H16BrNO3S |
详情 |
详情
|
(VII) |
41816 |
2-methyl-6-[(4-methylphenyl)sulfonyl]-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzazepine
|
|
C19H19N3O2S |
详情 |
详情
|
(VIII) |
41817 |
2-methyl-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzazepine
|
318237-73-9 |
C12H13N3 |
详情 | 详情
|
(IX) |
41818 |
[2-methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(1H)-yl](4-nitrophenyl)methanone
|
|
C19H16N4O3 |
详情 |
详情
|
(X) |
41819 |
(4-aminophenyl)[2-methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(1H)-yl]methanone
|
|
C19H18N4O |
详情 |
详情
|
(XII) |
18941 |
p-nitrobenzoyl chloride; 4-nitrobenzoyl chloride
|
122-04-3 |
C7H4ClNO3 |
详情 | 详情
|
合成路线13
该中间体在本合成路线中的序号:
(I) Amination and cyclization of methyl 2-aminobenzoate (I) with acetonitrile in the presence of HCl at reflux gives 2-methyl-4-quinazolinone (II), which by chlorination by means of POCl3 in the presence of DIEA in refluxing toluene or in the absence at 120 °C yields 4-chloro-2-methylquinazoline (III). Finally, intermediate (III) is condensed with N-(4-methoxyphenyl)-N-methylamine (IV) in the presence of HCl in isopropanol .
【1】
Sirisoma, N., Pervin, A., Zhang, H. et al. Discovery of N-(4-methoxyphenyl)-N,2- dimethylquinazolin-4-amine, a potent apoptosis induced and efficacious anticancer agent with high blood brain barrier penetration. J Med Chem 2009, 52(8): 2341-51. |
【2】
Jaing, S., Cai, S.X., Pervin, A. et al. (Myrexis, Inc.; EpiCept Corp.). Compounds and therapeutical uses thereof. EP 1660092, JP 2007524637, US 2005137213, US 7618975, WO 2005003100. |
【3】
Cai, S.X., Anderson, M.B., Willardsen, A., Sirisoma, N.S., Zhang, H.,Suzuki, K. (Myriad Genetics, Inc.; EpiCept Corp.). Nitrogen containing bicyclic compounds and therapeutic use thereof EP 1833482, WO 2006074147. |
【4】
Anderson, M.B., Willardsen, J.A., Weiner, W.S. et al. (Myrexis, Inc.). Compounds and therapeutical uses thereof. US 2010069383. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11161 |
methyl 2-aminobenzoate; Methyl anthranilate
|
134-20-3 |
C8H9NO2 |
详情 | 详情
|
(II) |
69157 |
2-methyl-4-quinazolinone;2-Methyl-4-quinazolone;2-Methylquinazolone;3H-2-Methyl-4-oxoquinazoline;4-Hydroxy-2-methylquinazoline;2-Methyl-4-oxoquinazoline;2-Methyl-4(3H)-quinazolone;2-Methyl-4(3H)-quinazolinone;2-Methyl-3H-quinazolin-4-one |
1769-24-0 |
C9H8N2O |
详情 | 详情
|
(III) |
69158 |
4-chloro-2-methylquinazoline |
6484-24-8 |
C9H7ClN2 |
详情 | 详情
|
(IV) |
69159 |
4-methoxy-N-methylaniline hydrochloride |
|
C8H11NO.HCl |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(I)
【1】
雷光清,刘晓珍,穆报春,等.祛痰新药氨溴索的合成方法研究.中国药物化学杂志,2000,10:205. |
【2】
Liebenow W,Grafe I.2-Amino-3,5-dibromobenzylamines:EP,Patent 130,224,1985. |
【3】
于书海,田世雄,何文,等.盐酸氨溴索的合成.中国医药化工杂志,1996,27:435. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11161 |
methyl 2-aminobenzoate; Methyl anthranilate
|
134-20-3 |
C8H9NO2 |
详情 | 详情
|
(III) |
69545 |
methyl 2-amino-3,5-dibromobenzoate;Methyl 3,5-dibromoanthranilate |
606-00-8 |
C8H7Br2NO2 |
详情 | 详情
|
(IV) |
69546 |
2-amino-3,5-dibromobenzohydrazide |
97096-13-4 |
C7H7Br2N3O |
详情 | 详情
|
(V) |
69547 |
N'-(2-amino-3,5-dibromobenzoyl)methanesulfonohydrazide |
|
C8H9Br2N3O3S |
详情 |
详情
|
(VI) |
19581 |
trans-4-Aminocyclohexanol;trans-4-Amino-1-cyclohexanol;trans-4-Amino-1-cyclohexanol; |
27489-62-9 |
C6H13NO |
详情 | 详情
|
(VII) |
69548 |
trans-4-((E)-(2-amino-3,5-dibromobenzylidene)amino)cyclohexanol |
50910-53-7 |
C13H16Br2N2O |
详情 | 详情
|
合成路线15
该中间体在本合成路线中的序号:
(I)
【1】
Cirera X,Lloveras P,Andreoli Rovati R.trans-4-Hydroxy-N-(2aAmino-3,5-dibromobenzyl)cyclo-hexylamine:ES,Patent 19,830,525,701,1985. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11161 |
methyl 2-aminobenzoate; Methyl anthranilate
|
134-20-3 |
C8H9NO2 |
详情 | 详情
|
(II) |
69545 |
methyl 2-amino-3,5-dibromobenzoate;Methyl 3,5-dibromoanthranilate |
606-00-8 |
C8H7Br2NO2 |
详情 | 详情
|
(III) |
69567 |
(2-amino-3,5-dibromophenyl)methanol;2-Amino-3,5-dibromobenzylalcohol |
50739-76-9 |
C7H7Br2NO |
详情 | 详情
|
(IV) |
69568 |
2,4-dibromo-6-(chloromethyl)aniline |
|
C7H6Br2ClN |
详情 |
详情
|
(V) |
69565 |
trans-4-aminocyclohexyl acetate |
|
C8H15NO2 |
详情 |
详情
|